Clinical trials

  • Gilteritinib for Acute myeloid leukemia (newly diagnosed, FLT3-mutated, non-M3)
  • DATOPOTAMAB DERUXTECAN for Triple-negative breast cancer | Brain metastases
  • ALE1 for Hypophosphatasia
  • INSULIN HUMAN for Persistent corneal epithelial defect
  • WEF-001 for Advanced KRAS‑mutant solid tumours
  • MANNITOL for End-stage renal disease | Kidney transplantation
  • [68GA]NODAGA-GLU(CYCLO[-ARG-GLY-ASP-D-TYR-LYS)]2 for Chronic ischemic heart disease
  • DEXMEDETOMIDINE for Procedural sedation | Procedural pain
  • ABD-3001 for Acute myeloid leukemia (relapsed/refractory) | Myelodysplastic syndrome (high/very-high risk)
  • Tacrolimus for Lung transplantation
  • LEVOSIMENDAN for Failure to wean from invasive ventilation
  • fexofenadine hydrochloride for Advanced non-small cell lung cancer